ArticleCurrent oncology (Toronto, Ont.)2025

Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.

Jerry Shu-Hung Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.